Market Cap

Dermapharm Holding SE Market Capitalization:

€2.10 Billion

EUR as of Jan. 1, 2026

US$2.47 Billion

business Dermapharm Holding SE Company Profile

Dermapharm Holding SE Main Stock Listings

Market Capitalization History of Dermapharm Holding SE

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
MERCK Kommanditgesellschaft auf Aktien $62.01 B
Zoetis Inc. $55.81 B
Takeda Pharmaceutical Company Limited $45.42 B
Haleon plc $44.50 B
Teva Pharmaceutical Industries Limited $35.85 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Dermapharm Holding SE market cap

Date Market Cap YoY Change
Jan. 1, 2026 €2.10 B -1.76%
Jan. 1, 2025 €2.14 B -4.65%
Jan. 1, 2024 €2.24 B 7.13%
Jan. 1, 2023 €2.09 B -49.83%
Jan. 1, 2022 €4.17 B 24.16%
Jan. 1, 2021 €3.36 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Dermapharm Holding SE Categories

Germany languages Healthcare languages Drug Manufacturers—Specialty & Generic
Germany Healthcare Germany Drug Manufacturers—Specialty & Generic

Stocks & Indices

Dermapharm Holding SE has the following listings and related stock indices.


Stock: FSX: DMP

Stock: XETR: DMP

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.